Longeveron (LGVN) Gross Margin (2020 - 2026)
Longeveron (LGVN) recorded quarterly Gross Margin of 66.33% in Q1 2026, down 5.79% quarter-over-quarter from 70.41% in Q4 2025, and down 585.0% on a YoY basis from 13.68% in Q1 2025.
Longeveron (LGVN) Gross Margin (2020 - 2026) Analysis & Trends
Longeveron's Gross Margin history runs 7 years deep, the most recent figure standing at 66.33% for Q1 2026.
- In Q1 2026, Gross Margin fell 585.0% year-over-year to 66.33%; the TTM figure through Mar 2026 stood at 65.13% (down 1716.0% YoY), while the FY2025 annual figure was 66.97%, down 1179.0% from the prior year.
- Gross Margin was 66.33% for Q1 2026 at Longeveron, down from 70.41% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 92.0% in Q3 2022 to a low of 45.45% in Q4 2022.
- Historically, Gross Margin has averaged 52.02% across 5 years, with a median of 60.04% in 2024.
- The sharpest annual moves came in 2022 and 2024: Gross Margin slumped 7847 bps in 2022, then surged 9107 bps in 2024.
- A 5-year view of Gross Margin shows it stood at 45.45% in 2022, then soared by 93 bps to 3.17% in 2023, then jumped by 2869 bps to 87.89% in 2024, then decreased by 20 bps to 70.41% in 2025, then retreated by 6 bps to 66.33% in 2026.
- The last three Gross Margin figures came in at 66.33% (Q1 2026), 70.41% (Q4 2025), and 91.24% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 79.04% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 86.85% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Longeveron | 20.35 Bn | 20.33 Bn | 264,000.00 | 66.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 66.33% |
| Dec 31, 2025 | 70.41% |
| Sep 30, 2025 | 91.24% |
| Jun 30, 2025 | 46.20% |
| Mar 31, 2025 | 72.18% |
| Dec 31, 2024 | 87.89% |
| Sep 30, 2024 | 88.23% |
| Jun 30, 2024 | 73.50% |
| Mar 31, 2024 | 60.04% |
| Dec 31, 2023 | -3.17% |
| Sep 30, 2023 | 36.00% |
| Jun 30, 2023 | 42.86% |
| Mar 31, 2023 | 27.24% |
| Dec 31, 2022 | -45.45% |
| Sep 30, 2022 | 92.00% |
| Jun 30, 2022 | 34.33% |
| Mar 31, 2022 | 44.59% |
| Dec 31, 2021 | 33.01% |
| Sep 30, 2021 | 70.69% |
| Jun 30, 2021 | 42.54% |